<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="medium, provided the original author(s) and the source are cited.vim.2019.0167.pdf" exact="influenza" post="virus virus evolution universal vaccines immune specificity polyclonal responses"/>
 <result pre="(23). Currently, major efforts are underway to develop a universal" exact="influenza" post="virus vaccine that would provide broadly protective immunity for"/>
 <result pre="virus vaccine that would provide broadly protective immunity for all" exact="influenza" post="A viruses (IAVs). In this brief piece, we suggest"/>
 <result pre="brief piece, we suggest that the search for a universal" exact="influenza" post="virus vaccination strategy must consider the inclusion of multiple"/>
 <result pre="through the human population. Due to the antigenic evolution of" exact="influenza" post="viruses, influenza vaccine compositions are examined every year and"/>
 <result pre="human population. Due to the antigenic evolution of influenza viruses," exact="influenza" post="vaccine compositions are examined every year and adjusted as"/>
 <result pre="lethal IAV strains into the human population, have made improving" exact="influenza" post="vaccination a public health priority (27). Creating a universal"/>
 <result pre="influenza vaccination a public health priority (27). Creating a universal" exact="influenza" post="vaccine has long been a goal of influenza researchers."/>
 <result pre="a universal influenza vaccine has long been a goal of" exact="influenza" post="researchers. In the late 70s, CD8+ T cell responses"/>
 <result pre="researchers. In the late 70s, CD8+ T cell responses to" exact="influenza" post="were discovered to have broadly crossreactive specificities to peptides"/>
 <result pre="the population after infection or thanks to immunization with seasonal" exact="influenza" post="vaccines. A few years ago, it was found that"/>
 <result pre="Monoclonal antibodies and polyclonal sera have been shown to select" exact="influenza" post="virus mutants dissimilarly in model systems (5,30,33). While viral"/>
 <result pre="T cells) in driving such changes. The objective of universal" exact="influenza" post="HA vaccines is to generate a specific immunity in"/>
 <result pre="found in the review from Bloom and colleagues (31). First," exact="influenza" post="is an acute and limited infection in immunocompetent individuals."/>
 <result pre="with various viruses such as the human immunodeficiency virus (HIV)," exact="lymphocytic choriomeningitis," post="hepatitis, or herpes viruses (3,4,14,18–20,25,28). In these infections, the"/>
 <result pre="typically observed for acute infections. In contrast, in immunocompromised individuals," exact="influenza" post="infection becomes more protracted, lasts for weeks, and is"/>
 <result pre="of novel specificity selections. Furthermore, the segmented nature of the" exact="influenza" post="virus genome complicates the selection of multiple mutation variants."/>
 <result pre="While the generation of quasi-species virus is well known during" exact="influenza" post="virus replication, the selection of multi-epitopic variants on different"/>
 <result pre="may be gathered from chronic infections such as HIV or" exact="hepatitis" post="C virus. In these infections, the virus can escape"/>
 <result pre="pool of virus variants for selection, a concept shared by" exact="influenza" post="viruses. For HIV, preventing viral replication using combinations of"/>
 <result pre="highly active antiretroviral therapies, is now the basis of viral" exact="suppression" post="and has changed the lives of HIV-infected patients worldwide"/>
 <result pre="a fate that is also true for the treatment of" exact="influenza" post="with adamantanes. In a similar manner, a host response"/>
 <result pre="NIAID, Bethesda, MD. References References 1.AltmanMO, AngelM, KosikI, et al.Human" exact="influenza" post="A virus hemagglutinin glycan evolution follows a temporal pattern"/>
 <result pre="5.DavisAKF, McCormickK, GuminaME, et al.Sera from individuals with narrowly focused" exact="influenza" post="virus antibodies rapidly select viral escape mutations in ovo."/>
 <result pre="al.Deep sequencing reveals potential antigenic variants at low frequencies in" exact="influenza" post="A virus-infected humans. J Virol2016;90:3355–336526739054 7.EffrosRB, DohertyPC, GerhardW, et"/>
 <result pre="cross-reactive and virus-specific T-cell populations after immunization with serologically distinct" exact="influenza" post="A viruses. J Exp Med1977;145:557–568233901 8.EhrlichPNobel Lecture, December 11,"/>
 <result pre="Elsevier Publishing Company, 1967. 9.EkiertDC, and WilsonIABroadly neutralizing antibodies against" exact="influenza" post="virus and prospects for universal therapies. Curr Opin Virol2012;2:134–14122482710"/>
 <result pre="universal therapies. Curr Opin Virol2012;2:134–14122482710 10.EpsteinSL, and PriceGECross-protective immunity to" exact="influenza" post="A viruses. Expert Rev Vaccines2010;9:1325–134121087110 11.EpsteinSLPrior H1N1 influenza infection"/>
 <result pre="immunity to influenza A viruses. Expert Rev Vaccines2010;9:1325–134121087110 11.EpsteinSLPrior H1N1" exact="influenza" post="infection and susceptibility of Cleveland Family Study participants during"/>
 <result pre="Dis2006;193:49–5316323131 12.HensleySE, DasSR, BaileyAL, et al.Hemagglutinin receptor binding avidity drives" exact="influenza" post="A virus antigenic drift. Science2009;326:734–73619900932 13.HoelzerK, MurciaPR, BaillieGJ, et"/>
 <result pre="Science2009;326:734–73619900932 13.HoelzerK, MurciaPR, BaillieGJ, et al.Intrahost evolutionary dynamics of canine" exact="influenza" post="virus in naïve and partially immune dogs. J Virol2010;84:5329–533520219907"/>
 <result pre="progression. Nat Med1995;1:330–3367585062 15.KrammerF, and PalesePAdvances in the development of" exact="influenza" post="virus vaccines. Nat Rev Drug Discov2015;14:167–18225722244 16.KrammerFNovel universal influenza"/>
 <result pre="of influenza virus vaccines. Nat Rev Drug Discov2015;14:167–18225722244 16.KrammerFNovel universal" exact="influenza" post="virus vaccine approaches. Curr Opin Virol2016;17:95–10326927813 17.LaskeySB, and SilicianoRFA"/>
 <result pre="and ZinkernagelRMImmunobiology of cytotoxic T-cell resistant virus variants studies on" exact="lymphocytic choriomeningitis" post="virus (LCMV). Semin Virol1996;7:3–11 21.MurciaPR, BaillieGJ, DalyJ, et al.Intra-"/>
 <result pre="BaillieGJ, DalyJ, et al.Intra- and interhost evolutionary dynamics of equine" exact="influenza" post="virus. J Virol2010;84:6943–695420444896 22.MurciaPR, BaillieGJ, StackJC, et al.Evolution of"/>
 <result pre="virus. J Virol2010;84:6943–695420444896 22.MurciaPR, BaillieGJ, StackJC, et al.Evolution of equine" exact="influenza" post="virus in vaccinated horses. J Virol2013;87:4768–477123388708 23.NgonoAE, and ShrestaSImmune"/>
 <result pre="al.Effects of egg-adaptation on receptor-binding and antigenic properties of recent" exact="influenza" post="A (H3N2) vaccine viruses. J Gen Virol2016;97:1333–134426974849 25.PeweL, WuGL,"/>
 <result pre="a virus-induced demyelinating disease. Immunity1996;5:253–2628808680 26.PicaN, and PalesePToward a universal" exact="influenza" post="virus vaccine: prospects and challenges. Annu Rev Med2013;64:189–20223327522 27."/>
 <result pre="the number of nonoverlapping antigenic areas on Hong Kong (H3N2)" exact="influenza" post="virus hemagglutinin with monoclonal antibodies and the selection of"/>
 <result pre="significance. Virology1980;104:139–1486156537 31.XueKS, MonclaLH, BedfordT, et al.Within-host evolution of human" exact="influenza" post="virus. Trends Microbiol2018;26:781–79329534854 32.XueKS, Stevens-AyersT, CampbellAP, et al.Parallel evolution"/>
 <result pre="virus. Trends Microbiol2018;26:781–79329534854 32.XueKS, Stevens-AyersT, CampbellAP, et al.Parallel evolution of" exact="influenza" post="across multiple spatiotemporal scales. Elife2017;6:e2687528653624 33.YewdellJ, WebsterR, and GerhardWAntigenic"/>
 <result pre="WebsterR, and GerhardWAntigenic variation in three distinct determinants of an" exact="influenza" post="type A haemagglutinin molecule. Nature1979;279:246–24886955 34.YewdellJW, CatonAJ, and GerhardWSelection"/>
 <result pre="type A haemagglutinin molecule. Nature1979;279:246–24886955 34.YewdellJW, CatonAJ, and GerhardWSelection of" exact="influenza" post="A virus adsorptive mutants by growth in the presence"/>
 <result pre="35.ZinkernagelRM, and DohertyPCRestriction of in vitro T cell-mediated cytotoxicity in" exact="lymphocytic choriomeningitis" post="within a syngeneic or semiallogeneic system. Nature1974;248:701–7024133807 36.ZostSJ, ParkhouseK,"/>
 <result pre="or semiallogeneic system. Nature1974;248:701–7024133807 36.ZostSJ, ParkhouseK, GuminaME, et al.Contemporary H3N2" exact="influenza" post="viruses have a glycosylation site that alters binding of"/>
</results>
